Koyfin Home > Directory > Health Care > Kezar Life Sciences Inc > EBIT

Kezar Life Sciences Inc EBIT Chart (KZR)

Kezar Life Sciences Inc annual/quarterly EBIT from 2017 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Kezar Life Sciences Inc EBIT for the quarter ending June 06, 2020 was $-10m a 1.75% decrease of 0m year over year
  • Kezar Life Sciences Inc EBIT for the last 12 months ending June 06, 2020 was $-40m a 15.59% decrease of -6m year over year
  • Kezar Life Sciences Inc Annual EBIT for 2019 was $-37m a 33.79% decrease of -13m from 2018
  • Kezar Life Sciences Inc Annual EBIT for 2018 was $-25m a 64.62% decrease of -16m from 2017
  • Kezar Life Sciences Inc Annual EBIT for 2017 was $-9m a -2.75% increase of 0m from 2016
Other Income Statement Metrics:
  • Kezar Life Sciences Inc EBITDA for the quarter ending September 09, 2018 was $-6m a 64.53% decrease of -4m year over year
  • Kezar Life Sciences Inc Net Income for the quarter ending September 09, 2018 was $-6m a 63.27% decrease of -4m year over year
View Chart On Koyfin

Quarterly KZR EBIT Data

06/2020$-10m
03/2020$-10m
12/2019$-10m
09/2019$-10m
06/2019$-9m
03/2019$-8m
12/2018$-6m
09/2018$-6m
06/2018$-7m
03/2018$-5m

Annual KZR EBIT Data

2019$-37m
2018$-25m
2017$-9m
2016$-9m